In AML, increased expression of BCL2 family proteins in leukemic blasts has been reported, and the majority of AML stem cells express aberrantly high levels of BCL2 and are dependent on BCL2 for survival. This evidence concerns the gene BCL2 and acute myeloid leukemia.